First step in management of raised intracranial pressure-
What is the most common cause of pneumonia in early onset sepsis in neonates?
A 6-year-old boy presents with fever and chills, cough, rapid breathing, difficulty breathing, and chest pain. A culture from a respiratory sample shows Gram-positive bacteria. What is the most likely organism causing this infection?
According to WHO guidelines for community health workers, which drug is commonly used in the management of acute respiratory infections?
In a case of meningitis, Neisseria meningitides was grown in culture after 48 hours. Which measure is to be taken immediately ?
What is a likely diagnosis for a patient with persistent fever after treatment for pneumonia?
Which of the following is an ideal method to prevent aspiration pneumonia?
Which is a minor criterion for diagnosis of RF according to modified Jones criteria?
To prevent ventilator associated pneumonia, the most effective and evidence based results are seen with which of the following for critically ill patients:
A patient in ICU and on ventilator develops cough with fever. The gram-staining on microscopy will show:
Explanation: ***Airway maintenance*** - Maintaining a **patent airway** is the absolute first step in managing any critically ill patient, including those with raised ICP, to ensure adequate **oxygenation and ventilation** [1]. - Without proper airway management, the brain will suffer from **hypoxia**, which can worsen cerebral edema and further increase ICP, leading to a poorer prognosis. *Breathing* - While essential in the **ABCs (Airway, Breathing, Circulation)**, ensuring adequate breathing (ventilation) comes immediately after securing the airway [1]. - An obstructed airway will prevent effective breathing, making airway maintenance the priority. *mannitol* - **Mannitol** is an osmotic diuretic used to reduce ICP by drawing fluid from the brain into the vasculature, but it is a **pharmacological intervention** that follows initial stabilization of the ABCs. - Administering mannitol without first securing the airway and ensuring ventilation could be detrimental if the patient is hypoxic. *Loading dose of phenytoin* - Administering a **loading dose of phenytoin** is primarily for seizure prophylaxis or treatment, which may be necessary in some cases of elevated ICP, but it is not the **immediate first step** in managing acute ICP elevation. - Seizure control is important, but airway, breathing, and circulation take precedence in the initial stabilization phase.
Explanation: ***Group B streptococcus*** - **Group B Streptococcus (GBS)** is the leading cause of **early-onset sepsis** and pneumonia in neonates, typically acquired during passage through the birth canal. - Maternal GBS colonization is a significant risk factor, and GBS can cause **severe respiratory distress** in affected newborns. *H influenzae* - **_Haemophilus influenzae_** is a more common cause of **late-onset sepsis** or pneumonia in infants and children, rather than early-onset neonatal disease. - While it can cause neonatal infections, it is much less frequent than GBS in the early-onset period. *Coagulase positive staph aureus* - **_Staphylococcus aureus_** is a common cause of **nosocomial infections** or late-onset sepsis in neonates, particularly in ventilated or catheterized infants. - It is not the most common pathogen for community-acquired **early-onset neonatal pneumonia**. *Listeria* - **_Listeria monocytogenes_** can cause severe neonatal sepsis and pneumonia, often associated with maternal consumption of contaminated food. - While it is a significant pathogen, it is less common overall than GBS as a cause of early-onset neonatal pneumonia in most regions.
Explanation: ***Streptococcus pneumoniae*** - This clinical picture describes typical symptoms of **pneumonia** in a child, including fever, cough, rapid and difficult breathing, and chest pain. - **_Streptococcus pneumoniae_** is the most common bacterial cause of community-acquired pneumonia in children. The respiratory sample showing gram-positive bacteria further supports this. *Staphylococcus aureus* - While **_Staphylococcus aureus_** can cause pneumonia, it is less common than _Streptococcus pneumoniae_ in community-acquired cases in healthy children and often associated with more severe, necrotizing forms or post-viral infections. - While it is a **Gram-positive bacterium**, its clinical presentation would not be the most likely first choice for typical pneumonia symptoms in this age group. *Propionibacterium acnes* - **_Propionibacterium acnes_** (now *Cutibacterium acnes*) is primarily associated with **acne vulgaris** and, less commonly, opportunistic infections related to implanted devices or some rare soft tissue infections. - It is not a typical cause of primary respiratory infections like pneumonia. *Streptococcus pyogenes* - **_Streptococcus pyogenes_** (Group A Streptococcus) is known for causing **pharyngitis** (strep throat), skin infections (impetigo, cellulitis), and scarlet fever. - While it can rarely cause pneumonia, it is not a common cause, and the constellation of symptoms points more strongly to _Streptococcus pneumoniae_.
Explanation: ***Cotrimoxazole*** - **Cotrimoxazole (trimethoprim-sulfamethoxazole)** was historically recommended by WHO for community health workers in resource-limited settings for the treatment of **acute respiratory infections (ARIs)**. - It is effective against common bacterial pathogens causing ARIs, such as *Streptococcus pneumoniae* and *Haemophilus influenzae*. - **Note:** Current WHO IMCI (Integrated Management of Childhood Illness) guidelines now recommend **amoxicillin** as first-line treatment for pneumonia in children, though cotrimoxazole remains an alternative in specific contexts or where amoxicillin is unavailable. *Chloramphenicol* - **Chloramphenicol** is a potent broad-spectrum antibiotic but is generally reserved for severe infections due to potential side effects like **bone marrow suppression** (aplastic anemia). - It is not a first-line drug for routine community-level management of uncomplicated ARIs according to WHO guidelines. *Benzyl penicillin* - **Benzyl penicillin** (Penicillin G) is effective against many streptococcal infections but has a narrower spectrum compared to cotrimoxazole. - Its use in the community setting for ARIs is limited due to the need for **parenteral administration**, making it impractical for community health workers managing outpatient cases. *Gentamycin* - **Gentamycin** is an aminoglycoside antibiotic primarily used for severe Gram-negative bacterial infections, often in hospital settings. - It is administered parenterally and is not recommended by WHO for routine community-based treatment of ARIs due to the risk of **nephrotoxicity** and **ototoxicity**, and its limited effectiveness against common ARI pathogens.
Explanation: ***Correct: Antibiotic treatment of contacts*** - **Chemoprophylaxis is the immediate priority** for close contacts of confirmed *Neisseria meningitidis* cases - Should be administered **within 24 hours** of case identification to prevent secondary cases - **Recommended antibiotics**: Rifampicin (2 days), Ciprofloxacin (single dose), or Ceftriaxone (single dose) - **Close contacts include**: household members, daycare contacts, anyone directly exposed to patient's oral secretions, healthcare workers exposed to respiratory secretions - This is the **most effective immediate measure** to prevent transmission as meningococcal disease has a 2-10 day incubation period *Incorrect: Isolation of contacts* - **Contacts do NOT require isolation** according to WHO and CDC guidelines - Only the **index patient** requires droplet precautions for 24 hours after starting appropriate antibiotics - Contacts can continue normal activities while on chemoprophylaxis and should monitor for symptoms - Isolating healthy contacts is not evidence-based and creates unnecessary social disruption *Incorrect: Vaccination of contacts* - Meningococcal vaccination is important for **long-term prevention** but not immediate post-exposure prophylaxis - Vaccines take **7-14 days** to develop protective immunity, too slow for immediate protection - Recommended in **outbreak settings** or for high-risk groups as an adjunct to chemoprophylaxis - Does not replace the need for immediate antibiotic prophylaxis *Incorrect: All of the options* - **Only antibiotic chemoprophylaxis** is the immediate measure required - Isolation of contacts is not standard practice for meningococcal disease - Vaccination is a secondary/long-term measure, not immediate - The question asks for the **immediate** measure, which is unequivocally chemoprophylaxis
Explanation: ***Empyema (pleural effusion with infection)*** - **Empyema** is a collection of pus in the pleural space, often a complication of pneumonia, and can cause **persistent fever** despite appropriate antibiotic treatment for the initial pneumonia [1]. - The continued presence of infection in the pleural space, which is not directly targeted by standard pneumonia treatment, can lead to prolonged inflammatory symptoms [1]. *Fungal pneumonia* - While fungal pneumonia can cause persistent fever, it typically does not develop *after* treatment for bacterial pneumonia unless the patient is immunocompromised or has specific environmental exposures . - It would usually be considered if initial bacterial treatment failed or if there were specific risk factors for fungal infection. *Bronchogenic carcinoma* - This is a long-term, chronic condition that can cause fever, but it is unlikely to present as a *persistent fever immediately after treatment* for an acute pneumonia episode. - Fever associated with malignancy often has a different pattern and is usually accompanied by other systemic symptoms like weight loss. *Lung abscess* - A **lung abscess** is a pus-filled cavity within the lung parenchyma, which can cause persistent fever. - However, fever from a lung abscess often responds partially to antibiotics, and the diagnosis is usually made earlier during the initial pneumonia course or when treatment fails to resolve the infiltrates.
Explanation: ***Endotracheal tube (cuffed)*** - A cuffed endotracheal tube forms a **seal** in the trachea, effectively preventing aspiration of gastric contents or oral secretions into the lungs. - This method is particularly crucial before and during surgical procedures involving general anesthesia, where normal airway protective reflexes are abolished. *Full stomach* - A **full stomach** significantly increases the risk of aspiration, as there is more gastric content available to be regurgitated into the airway. - This is a contraindication for immediate induction of general anesthesia and often necessitates a rapid sequence intubation. *Increase the intra abdominal pressure* - Increasing **intra-abdominal pressure** (e.g., due to obesity, insufflation for laparoscopy) can push gastric contents towards the esophagus, thereby increasing the risk of reflux and aspiration. - This effect is undesirable and directly contributes to aspiration risk rather than preventing it. *Inhalational anesthetic* - **Inhalational anesthetics** depress airway reflexes, making the patient more susceptible to aspiration. - While they are essential for maintaining anesthesia, they do not prevent aspiration; rather, other measures like intubation are necessary to counteract their effects.
Explanation: ***
Explanation: Oral hygiene procedures plus chlorhexidine - **Chlorhexidine** mouthwash, when combined with mechanical oral hygiene, significantly reduces the oral bacterial load, preventing aspiration of pathogenic bacteria into the lungs. - This comprehensive approach is a **gold standard** strategy for VAP prevention in critically ill patients, supported by strong evidence. *Betadine mouthwash* - While Betadine (povidone-iodine) has **antiseptic properties**, its efficacy in preventing VAP is not as well-established or consistently supported by evidence as chlorhexidine. - There are concerns about potential **mucosal irritation** and systemic absorption with prolonged use in critically ill patients. *Powered brushing* - Though powered brushing can provide effective plaque removal, it primarily focuses on **mechanical cleaning** without the added antimicrobial benefits of an antiseptic agent like chlorhexidine. - Its effectiveness alone in preventing VAP has **not been shown to be superior** to comprehensive oral care including antiseptics. *Manual brushing* - Manual brushing is a basic component of oral hygiene but, similar to powered brushing, lacks the **antimicrobial action** necessary to drastically reduce bacterial colonization in critically ill, intubated patients. - It is important for general oral cleanliness but **insufficient on its own** for preventing VAP effectively.
Explanation: ***Gram negative bacilli*** - **Ventilator-associated pneumonia (VAP)** is most commonly caused by **Gram-negative bacilli**, particularly in late-onset VAP (>5 days of mechanical ventilation). - Common pathogens include *Pseudomonas aeruginosa*, *Klebsiella pneumoniae*, *Escherichia coli*, and *Acinetobacter baumannii*, which are prevalent in the ICU environment. - These organisms commonly colonize the oropharynx of critically ill, intubated patients and can be aspirated into the lower respiratory tract, leading to pneumonia. - Gram-negative bacilli account for the **majority of VAP cases**, making this the most likely microscopic finding. *Gram negative cocci* - **Gram-negative cocci** like *Neisseria meningitidis* and *Neisseria gonorrhoeae* are primary causes of meningitis and sexually transmitted infections, respectively, and are not typical pathogens for VAP. - While *Moraxella catarrhalis* is a Gram-negative coccobacillus that can cause respiratory infections, it is uncommon in severe VAP cases compared to Gram-negative bacilli. *Gram variable organism* - The term **"Gram variable"** is rarely used in clinical microbiology to describe a consistent bacterial morphology; it usually refers to mixed staining results where some cells stain Gram-positive and others Gram-negative. - This description does not fit the typical profile of bacteria causing VAP and is not a standard morphological category for common VAP pathogens. *Gram positive bacilli* - **Gram-positive bacilli**, such as *Bacillus* species or *Corynebacterium* species, are generally not recognized as common causes of VAP. - Note: While **Gram-positive cocci** like *Staphylococcus aureus* (including MRSA) and *Streptococcus pneumoniae* are important VAP pathogens, they would appear as **cocci**, not bacilli, on microscopy. - The question specifically asks about morphology on Gram staining, and Gram-positive **bacilli** are not the predominant morphological pattern in VAP.
Get full access to all questions, explanations, and performance tracking.
Start For Free